Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
EO

WKN: A1XFUX | ISIN: IL0011313900 | Ticker:
NASDAQ
20.11.26 | 16:35
1,820 US-Dollar
+2,25 % +0,040
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EOCENE LTD Chart 1 Jahr
5-Tage-Chart
EOCENE LTD 5-Tage-Chart

Aktuelle News zur EOCENE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.11.EoCene Ltd. - 6-K, Report of foreign issuer1
02.10.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2-3.648The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE...
► Artikel lesen
09.09.Galmed Pharmaceuticals Ltd.: Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation198Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. (Yorkville) will be terminated effective immediately The Company has regained compliance with the...
► Artikel lesen
02.09.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer1
19.08.Galmed completes feasibility study for colon tissue assessment tech5
19.08.Galmed Pharmaceuticals Ltd.: Galmed Announces Successful First-in-Human Proof-of-Concept Clinical Study Results for Colospan's Novel Intraoperative Tissue Assessment Technology951The prospective, single-arm study enrolled 32 colorectal cancer patients at three leading clinical centers in Israel. The primary objective was to demonstrate...
► Artikel lesen
19.08.XFRA CAPITAL ADJUSTMENT INFORMATION - 19.08.2026585Das Instrument BOS DE000A41YFA8 HUGO BOSS AG NA Z.VERK. EQUITY wird cum Kapitalmassnahme gehandelt am 19.08.2026 und ex Kapitalmassnahme am 20.08.2026 The instrument BOS DE000A41YFA8 HUGO BOSS AG NA...
► Artikel lesen
17.08.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer2
EOCENE Aktie jetzt für 0€ handeln
17.08.Galmed Pharmaceuticals Ltd.: Galmed Announces First Time Results in Prostate Oncology Studies: Aramchol Demonstrates 3-4 Fold Increase in Cell Death Compared to Enzalutamide (XTANDI) Alone in Prostate Cancer Models452Xtandi® (enzalutamide) is indicated as monotherapy for the treatment of patients with non-metastatic prostate cancer (nmCSPC) at high risk of metastasis and for...
► Artikel lesen
28.07.Galmed advances Parkinson's drug formulation with higher CNS exposure4
28.07.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer1
16.07.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer25
08.07.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer2
22.06.Galmed completes acquisition of medical device firm Colospan1
22.06.Galmed schließt Übernahme des Medizintechnik-Unternehmens Colospan ab3
22.06.Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition388Colospan Ltd. ("Colospan") provides Galmed Pharmaceuticals Ltd. ("Galmed") (NASDAQ: GLMD) with a commercially ready product in the EU/Israel (CE marked under MDR)...
► Artikel lesen
22.06.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer1
10.06.Galmed Pharmaceuticals: Colospan Acquisition Creates GI-Focused Platform Targeting $6 Billion Market3
08.06.Galmed to acquire Colospan in $4.5M deal; shares down5
08.06.Galmed Pharmaceuticals Ltd.: Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market442Transaction will add FDA Breakthrough Device-Designated technology with active U.S. pivotal IDE trial, positioning Galmed to address one of colorectal surgery's...
► Artikel lesen
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1